4//SEC Filing
Kelly Leanne M. 4
Accession 0001824293-22-000010
CIK 0001824293other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:03 PM ET
Size
5.6 KB
Accession
0001824293-22-000010
Insider Transaction Report
Form 4
Kelly Leanne
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15$5.63/sh+50,000$281,500→ 50,000 totalExercise: $5.63Exp: 2032-02-15→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Reported late due to administrative error.
- [F2]Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.
Documents
Issuer
Vallon Pharmaceuticals, Inc.
CIK 0001824293
Entity typeother
Related Parties
1- filerCIK 0001398278
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:03 PM ET
- Size
- 5.6 KB